Our R&D Centre in Hyderabad is built on a vast area, providing comprehensive infrastructure for groundbreaking innovation. This investment in infrastructure is key to our status as one of the top pharma companies in India.
As a global leader in developing and manufacturing a wide range of brands and generics, including oncology and ARV drugs, our commitment to innovation drives our progress. Our pharmaceutical company in Hyderabad plays a crucial role in bridging the gap between cutting-edge drug discovery and the real-world needs of patients.
Launched first generic 'COVIFOR' (Remdesivir) in India for the treatment of COVID-19 (licensing agreement with Gilead Sciences Inc.)
Basic manufacturer of Oseltamivir (sub-licensing agreement with Hoffman-La Rosche, Switzerland).
Click here for more...
In the pharmaceutical industry, innovation is at the core of what we do. At Hetero Healthcare, we develop new drugs and therapeutic biological products through structured innovation strategies, ensuring we meet the demand for pharmaceutical manufacturers in India.
We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists.
Doctors
Formulation Products
Field Force
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
Read More
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
Read More
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
Read More
The Hetero Healthcare - Gastrocare Division proudly participated in the AIG Liver Conclave 2025 at HICC, Novotel, Hyderabad, held on September 26-27.
Read More
PatchMantra - A Patch. A Mantra. A Better Way to Heal A revolutionary platform bringing patch therapy to the forefront of modern healthcare.
Read More
Hetero Healthcare Ltd., one of India’s leading pharmaceutical companies, has launched Perzea, the most affordable biosimilar of Pertuzumab, in collaboration with Enzene Biosciences Ltd.
Read More
DIAQUIL Launch: A New Breakthrough in Diabetic Foot Care by the DIASPA team at Hetero Healthcare
Read More
The Telangana team received Blazers from our beloved Director Mr. Namburi Bose and Assoc.
Read More
Congratulations, esteemed members of our exceptional KRIS Team!
Read MoreThis is to bring in your notice that multiple news items are going in and out about our product Covifor and becoming viral in social media. We want to inform the public that our organization did not create that news. We are here to serve our nation and citizens by making the product available across the country. For any patient support or inquiries, we made ourselves available through TOLL-FREE NUMBER 1800 103 4696 and EMAIL ID : covifor@heterohealthcare.com. We request all the patient caretakers to contact us on our toll-free number where we can support on a timely basis.
With the helping hands of our doctors, let us fight CORONA.
Copyright ©2025 All Rights Reserved by Hetero Healthcare Limited.
